𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cells presenting tumor antigen

✍ Scribed by Michael R. Shurin

Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
160 KB
Volume
43
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Presentation of prostate tumor antigens
Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity
✍ Tjoa, Benjamin; Boynton, Alton; Kenny, Gerald; Ragde, Haakon; Misrock, S. Leslie πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 475 KB πŸ‘ 2 views

Dendritic cells (DCs) are "professional" antigen-presenting cells capable of stimulating T-cell proliferation and cytotoxicity when loaded with and presenting specific antigens, including tumor antigens. We demonstrated the stimulation of an autologous cytotoxic T-cell response elicited by DC loaded

Murine epidermal Langerhans cells and sp
Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells
✍ Philip J. Cohen; Peter A. Cohen; Steven A. Rosenberg; James J. MulΓ©; Stephen I. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 558 KB

## Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells We examined the ability of epidermal Langerhans cells and splenic dendritic cells to present tumor-associated antigens (Ag) to immune T cells. Methylcholanthrene (MCA)-induced subcu

Tumor-infiltrating dendritic cells are d
Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats
✍ Pascal Chaux; Nathalie Favre; Monique Martin; FranΓ§ois Martin πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 160 KB

Tumors are tolerated by the immune system notwithstanding the expression of tumor-associated antigens. PROb tumor cells, derived from a rat colon carcinoma, are rejected by tumor-immune hosts but give rise to progressive tumors in naive hosts. Paradoxically, these tumors are heavily infiltrated by d

Glycan modification of the tumor antigen
Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells
✍ Corlien A. Aarnoudse; Marieke Bax; Marta SΓ‘nchez-HernΓ‘ndez; Juan J. GarcΓ­a-Valle πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 291 KB

## Abstract Dendritic cells (DC) have gained much interest in the field of anticancer vaccine development because of their central function in immune regulation. However, the clinical application of __ex vivo__ cultured DC has significant disadvantages. A vaccine that targets dendritic cells __in v